Depression is a medical condition. It involves measurable changes in brain chemistry, brain structure, immune function, and gene expression. The two major international classification systems used by doctors worldwide both categorize it as a clinical disorder with specific diagnostic criteria, a known biological basis, and established treatments. It is not a character flaw, a phase, or ordinary sadness that a person should be able to shake off.
What Makes Depression a Medical Condition
A formal diagnosis of major depressive disorder requires at least five specific symptoms persisting nearly every day for a minimum of two weeks. At least one of those symptoms must be either a persistently low mood or a loss of interest or pleasure in nearly all activities. The other possible symptoms include significant changes in weight or appetite, insomnia or excessive sleeping, physical slowing or agitation visible to others, daily fatigue, feelings of worthlessness or inappropriate guilt, difficulty thinking or concentrating, and recurrent thoughts of death or suicide.
These criteria exist in both the DSM-5-TR (used primarily in the United States) and the ICD-11 (used internationally). The two systems are nearly identical in their requirements. The ICD-11 adds one additional symptom, hopelessness about the future, to its list. Both systems draw a clear line between clinical depression and normal emotional responses like grief: depression is diagnosed only when symptoms are persistent, pervasive, and represent a clear change from how a person previously functioned.
Roughly 5.7% of adults worldwide live with depression, making it one of the most common medical conditions on the planet. Women are affected at higher rates (6.9%) than men (4.6%).
How Depression Differs From Sadness
Everyone experiences sadness. Losing a job, ending a relationship, or grieving a loved one can bring intense emotional pain. The critical difference is duration, scope, and function. Sadness comes in waves, often triggered by specific thoughts or reminders, and it coexists with moments of laughter, connection, or enjoyment. Clinical depression sits on you constantly, nearly all day, nearly every day, for weeks or longer. It flattens your ability to feel pleasure in things that once mattered to you.
The ICD-11 specifically addresses bereavement: a depressive episode during grief is suggested when symptoms persist for a month or more without any periods of positive mood, when guilt and worthlessness extend beyond the loss itself, or when psychotic symptoms, suicidal thoughts, or visible physical slowing appear. In other words, even in situations where deep sadness is expected, depression can be identified as something distinct layered on top of it.
The Biology Behind It
Depression changes the brain in ways that can be seen and measured. The earliest biological theory focused on chemical messengers called neurotransmitters, particularly serotonin and norepinephrine. Medications that increase the availability of these chemicals in the brain do help many people, but the fact that those medications take weeks to work tells researchers something important: the real therapeutic action involves slower changes in how brain cells signal each other and which genes they activate. More recent work has also identified the brain’s reward and motivation system, which runs on dopamine, as a key player, especially in the loss of pleasure and drive that defines so much of the depressive experience.
Beyond chemistry, depression physically reshapes the brain over time. The hippocampus, a structure essential for memory and emotional regulation, tends to be smaller in people with depression. Longer total duration of illness, more episodes, and earlier age of onset are all associated with greater volume loss. One proposed explanation is that prolonged stress hormone exposure makes brain cells more vulnerable to damage, while simultaneously reducing levels of a protein called BDNF that normally supports cell growth, survival, and the formation of new connections between neurons. People with depression consistently have lower BDNF levels than healthy controls, and effective treatment raises those levels back up. In animal studies, mice with roughly half the normal amount of BDNF become susceptible to depressive behavior after even mild stress.
Depression Affects the Whole Body
One of the strongest pieces of evidence that depression is a systemic illness, not just a mood problem, is its impact on the body’s immune and inflammatory systems. People with depression show elevated levels of inflammatory markers like C-reactive protein (CRP), interleukin-6, and tumor necrosis factor-alpha. These inflammatory molecules can cross the barrier between the bloodstream and the brain, where they interfere with neurotransmitter production, impair the brain’s ability to form new connections, and activate immune cells within the brain itself. Inflammation also diverts tryptophan, the raw material the brain uses to make serotonin, into a different chemical pathway that produces neurotoxic byproducts instead.
The physical symptoms of depression are extensive and often surprising to people who think of it purely as an emotional problem. Around two-thirds of depressed patients in clinical settings report significant physical pain. Sleep architecture changes, appetite swings, digestive problems, heart rhythm irregularities, loss of sex drive, hair loss, changes in body temperature, nausea, dizziness, and a pervasive sense of physical heaviness or exhaustion are all documented somatic features. These symptoms have a clear neurobiological basis: pathways running from the brainstem to the spinal cord that normally filter and dampen pain signals from the body become impaired when serotonin and norepinephrine are dysregulated, effectively turning up the volume on physical discomfort.
Genetics Play a Real Role
Depression runs in families, and the genetic contribution is substantial. A large meta-analysis of twin studies estimated the heritability of major depressive disorder at about 37%. A Scottish family study found heritability estimates ranging from 28% to 44% depending on how shared family environment was accounted for. This means that roughly a third to nearly half of a person’s vulnerability to depression comes from inherited genetic factors. The remaining risk comes from life experiences, environment, and the interaction between the two.
One well-studied genetic variation affects how efficiently the brain releases BDNF, the growth-promoting protein mentioned earlier. People who carry this variant don’t produce less BDNF overall, but their brain cells are worse at releasing it when needed, effectively reducing its availability where it matters most. This is one example of how genetic differences create biological vulnerability, not destiny, but a real, measurable tilt toward illness under the right conditions.
Why the “Sickness” Question Matters
Whether someone calls depression a sickness, a disease, a disorder, or a medical condition, the clinical reality is the same. It has diagnostic criteria, biological markers, genetic roots, measurable changes in brain structure and immune function, and physical symptoms that extend well beyond mood. It responds to medical treatment. It can worsen, recur, and cause progressive damage to the brain when left untreated. None of this is true of ordinary sadness or a bad week.
The distinction matters because framing depression as something other than a medical condition often leads people to delay treatment, blame themselves, or face stigma from others who see it as weakness. Understanding that depression involves real physiological changes, from shrunken brain structures to elevated inflammatory proteins to disrupted neurotransmitter pathways, puts it squarely in the category of conditions that deserve the same medical attention as diabetes or heart disease.